drotrecogin alfa
Sign in to saveAlso known as drotrecogin alfa (activated), lyophilized, Autoprothrombin IIA, activated protein c, drotrecoginum alfa (activatum), Vitamin K-dependent protein C precursor, blood coagulation factor xiv (human), ly203638, drotrecogin
pharmaceutical drug
Chemical data
Drug data · ChEMBL
Withdrawn- Max clinical phase
- Approved
- Molecule type
- Protein
- First approval
- 2001
- Admin. routes
- parenteral
- Indications
- chronic kidney disease, Recurrent thrombophlebitis, pulmonary embolism, Sepsis
via ChEMBL · EBI
Research
744 papers- Drotrecogin alfa.Drugs of today (Barcelona, Spain : 1998) · 2004
- Drotrecogin alfa (activated).Drugs · 2002
- Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock.The American journal of the medical sciences · 2004
- Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis.Critical care medicine · 2003
- Drotrecogin alfa (activated) in adults with septic shock.The New England journal of medicine · 2012
via PubMed
Wikidata facts
- Official website
- www.xigris.com
- Has use
- medication
Show 4 more facts
- medical condition treated
- sepsis
- NCI Thesaurus ID
- C80267
- defined daily dose
- 40
- has characteristic
- biopharmaceutical
via Wikidata · CC0